Xtl Biopharmaceuticals (XTLB) Interest Coverage Ratio Growth (5y) (2014 - 2023)
Xtl Biopharmaceuticals (XTLB) Interest Coverage Ratio Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -15.70% |
| Jun 30, 2023 | 21.14% |
| Mar 31, 2023 | 18.17% |
| Sep 30, 2022 | -416.81% |
| Jun 30, 2022 | 78.13% |
| Mar 31, 2022 | 124.03% |
| Dec 31, 2018 | -15.65% |
| Sep 30, 2018 | 45.86% |
| Jun 30, 2018 | -15.16% |
| Mar 31, 2018 | -18.71% |
| Dec 31, 2017 | 27.41% |
| Sep 30, 2017 | 14.88% |
| Jun 30, 2017 | -15.78% |
| Mar 31, 2017 | 15.24% |
| Dec 31, 2016 | -65.43% |
| Sep 30, 2016 | 64.15% |
| Jun 30, 2016 | -28.93% |
| Mar 31, 2016 | 36.30% |
| Jun 30, 2015 | 48.02% |
| Mar 31, 2015 | 41.22% |